Paper
4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors.
Published Oct 1, 2005 · Junya Ishida, K. Hattori*, Hirofumi Yamamoto
Bioorganic & medicinal chemistry letters
Q2 SJR score
38
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
The 4-phenyl-1,2,3,6-tetrahydropyridine fragment enhances the potency of PARP-1 inhibitors, leading to highly potent benzamide analogues.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···